New diabetes research links blood glucose levels and voice
Glucose profiles of comprehensive and sampled CGM data corresponding to voice recordings. (a–c): Comprehensive CGM glucose profiles of ND, PD, T2D. (d–f): Sampled CGM data corresponding to voice recordings of ND, PD, T2D. (g–i): Cumulative distribution functions of glucose profiles from comprehensive and sampled data. The first column displays ND data, the second column displays PD data, the third column displays T2D data. ND, non-diabetic; PD, prediabetic; T2D, Type 2 diabetic. Credit: Scientific Reports (2024). DOI: 10.1038/s41598-024-69620-z

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports today—confirming the link between blood glucose levels and voice pitch and opening the door to future advancements in non-invasive glucose monitoring for people living with type 2 diabetes.

In “Linear Effects of Glucose Levels on Voice Fundamental Frequency in type 2 diabetes and Individuals with Normoglycemia,” researchers investigated how blood glucose levels influence the frequency of the voice in 505 participants across three glycemic statuses—non-diabetic, prediabetic, and type-2 diabetic.

Participants were fitted with continuous glucose monitors (CGMs) and recorded their voices multiple times daily for two weeks. The analysis revealed a linear relationship where an increase in CGM glucose levels corresponded to an increase in the fundamental frequency in the voice.

“By establishing a significant positive association between glucose levels and fundamental frequency, our study provides compelling justification for more research on using voice to predict and monitor glucose levels,” said Jaycee Kaufman, lead author and scientist at Klick Labs.

“Whereas current glucose monitoring methods are often invasive and inconvenient, voice-based glucose monitoring could be as easy as talking into a smartphone, which could change the game for the estimated 463 million people around the world living with type 2 diabetes.”

Klick Labs’ latest research marks another step forward in its ongoing commitment to advancing the detection and management of diabetes using voice tech and machine learning. Their October 2023 study in Mayo Clinic Proceedings: Digital Health demonstrated that voice and AI can screen for type 2 diabetes with high accuracy.

Previously, their “Screening for Impaired Glucose Homeostasis: A Novel Metric of Glycemic Control” research also appeared in Mayo Clinic Proceedings: Digital Health (May 2023), and their “Homeostasis as a proportional–integral control system” study was published in Nature Digital Medicine (May 2020).

More information:
Jaycee Kaufman et al, Linear effects of glucose levels on voice fundamental frequency in type 2 diabetes and individuals with normoglycemia, Scientific Reports (2024). DOI: 10.1038/s41598-024-69620-z

Provided by
Klick Applied Sciences

Citation:
New diabetes research links blood glucose levels and voice pitch (2024, August 28)
retrieved 13 September 2024
from https://medicalxpress.com/news/2024-08-diabetes-links-blood-glucose-voice.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What color is the sky on a sunny day?

Explore More

Ultra-processed foods pose unique dangers for people with type 2 diabetes

Consuming more ultra-processed foods — from diet sodas to packaged crackers to certain cereals and yogurts — is closely linked with higher blood sugar levels in people with Type 2

New hope for diabetic heart disease treatment

The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its “calming agent” action in turning off the body’s inflammatory response and preventing chronic inflammation, could also

Novel class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes, new study finds

Credit: Unsplash/CC0 Public Domain New research published in New England Journal of Medicine and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD)